Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021

Emergent BioSolutions (EBS) Tops Q4 EPS by 23c

February 24, 2022 4:35 PM EST

Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $4.50, $0.23 better than the analyst estimate of $4.27. Revenue for the quarter came in at $723.2 million versus the consensus estimate of $691.36 million.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

... More